Evidence map›Paper›PMID 26826298›Full record

ArticleBiomaterials2016

Structure-property relationship for in vitro siRNA delivery performance of cationic 2-hydroxypropyl-β-cyclodextrin: PEG-PPG-PEG polyrotaxane vectors.

Vivek D Badwaik, Emilio Aicart, Yawo A Mondjinou, Merrell A Johnson, Valorie D Bowman, David H Thompson

Abstract read
In one paragraph

Article in Biomaterials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vivek D BadwaikDepartment of Chemistry, Multi-disciplinary Cancer Research Facility, Bindley Bioscience Center, 1203 W. State Street, West Lafayette, IN 47907, USA.
Emilio AicartDepartment of Chemistry, Multi-disciplinary Cancer Research Facility, Bindley Bioscience Center, 1203 W. State Street, West Lafayette, IN 47907, USA.
Yawo A MondjinouDepartment of Chemistry, Multi-disciplinary Cancer Research Facility, Bindley Bioscience Center, 1203 W. State Street, West Lafayette, IN 47907, USA.
Merrell A JohnsonDepartment of Physics, Indiana University-Purdue University Indianapolis, IN 46202, USA.
Valorie D BowmanDiscovery Park, Hockmeyer Hall of Structural Biology, Purdue University, West Lafayette, IN 47907, USA.
David H ThompsonDepartment of Chemistry, Multi-disciplinary Cancer Research Facility, Bindley Bioscience Center, 1203 W. State Street, West Lafayette, IN 47907, USA. Electronic address: davethom@purdue.edu.

Funding

Transgenic Mouse Core Facility Shared Resource (TMCF-SR)P30CA023168 · NCI · PURDUE UNIVERSITY WEST LAFAYETTE · PI John Tesmer · 1985 to 2026
$43.4M
Development of Bioresponsive Lipids for Intracellular DeliveryR01GM087016 · NIGMS · PURDUE UNIVERSITY · PI THOMPSON, DAVID H · 2009 to 2012
$1.2M
NCI NIH HHS P30 CA023168NCI NIH HHS R21 CA15196NIGMS NIH HHS R01 GM087016
6 · The paper itself

Abstract

Nanoparticle-mediated siRNA delivery is a promising therapeutic approach, however, the processes required for transport of these materials across the numerous extracellular and intracellular barriers are poorly understood. Efficient delivery of siRNA-containing nanoparticles would ultimately benefit from an improved understanding of how parameters associated with these barriers relate to the physicochemical properties of the nanoparticle vectors. We report the synthesis of three Pluronic(®)-based, cholesterol end-capped cationic polyrotaxanes (PR(+)) threaded with 2-hydroxypropyl-β-cyclodextrin (HPβCD) for siRNA delivery. The biological data showed that PR(+):siRNA complexes were well tolerated (∼90% cell viability) and produced efficient silencing (>80%) in HeLa-GFP and NIH 3T3-GFP cell lines. We further used a multi-parametric approach to identify relationships between the PR(+) structure, PR(+):siRNA complex physical properties, and biological activity. Small angle X-ray scattering and cryoelectron microscopy studies reveal periodicity and lamellar architectures for PR(+):siRNA complexes, whereas the biological assays, ζ potential measurements, and imaging studies suggest that silencing efficiency is influenced by the effective charge ratio (ρeff), polypropylene oxide (PO) block length, and central PO block coverage (i.e., rigidity) of the PR(+) core. We infer from our findings that more compact PR(+):siRNA nanostructures arising from lower molecular weight, rigid rod-like PR(+) polymer cores produce improved silencing efficiency relative to higher molecular weight, more flexible PR(+) vectors of similar effective charge. This study demonstrates that PR(+):siRNA complex formulations can be produced having higher performance than Lipofectamine(®) 2000, while maintaining good cell viability and siRNA sequence protection in cell culture.

Indexed as

2-Hydroxypropyl-beta-cyclodextrinAnimalsbeta-CyclodextrinsCell DeathCell SurvivalCyclodextrinsDNAFlow CytometryGene Knockdown TechniquesGenetic VectorsGreen Fluorescent ProteinsHeLa CellsHumansMiceNIH 3T3 CellsPlasmids2-Hydroxypropyl-beta-cyclodextrinbeta-CyclodextrinsCyclodextrinsDNAGreen Fluorescent ProteinsPoloxamerpoly(ethylene glycol)-block-poly(propylene glycol)-block-poly(ethylene glycol) copolymerPolyethylene GlycolspolyrotaxanePropylene GlycolsRNA, Small InterferingRotaxanesCryoelectron microscopyGene silencingPolyrotaxanesiRNASmall angle X-ray scatteringβ-Cyclodextrin

Identifiers

PMID26826298
PMCPMC4755830

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.